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This article presents a schematic review of the clinical manifestations of occupational neurologic 
disorders in Korea and discusses the toxicologic implications of these conditions. Vascular encepha-
lopathy, parkinsonism, chronic toxic encephalopathy, cerebellar dysfunction, peripheral neuropa-
thy, and neurodegenerative diseases are common presentations of occupational neurotoxic syn-
dromes in Korea. Few neurotoxins cause patients to present with pathognomic neurologic syn-
drome. Detailed neurologic examinations and categorization of the clinical manifestations of neu-
rologic disorders will improve the clinical management of occupational neurologic diseases. Phy-
sicians must be aware of the typical signs and symptoms of possible exposure to neurotoxins, and 
they should also pay attention to less-typical, rather-vague symptoms and signs in workers because 
the toxicologic characteristics of occupational neurologic diseases in Korea have changed from typ-
ical patterns to less-typical or equivocal patterns. This shift is likely to be due to several years of low-
dose exposure, perhaps combined with the effects of aging, and new types of possibly toxicant-re-
lated neurodegenerative diseases. Close collaboration between neurologists and occupational 
physicians is needed to determine whether neurologic disorders are work-related.
  J Clin Neurol 2010;6:64-72
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Introduction
Chemicals capable of damaging the central nervous system 
(CNS) are ubiquitous in the environment, and especially in oc-
cupational settings. Industrial processes are major sources of 
some of the most well-known neurotoxicants. According to 
the United States Environmental Protection Agency, more than 
65,000 commercial chemicals are currently used in the US, 
and 2,000-3,000 new chemicals are added each year.
1 Approx-
imately one-quarter of these chemicals are suspected neuro-
toxins.
The nervous system is vulnerable to the effects of certain 
chemicals found in the work environment. Clinical disorders 
of the CNS have varying presentations, often involving a host 
of nonspecific symptoms. Multiple syndromes may occur in 
response to a single neurotoxin, depending on the level and du-
ration of the exposure. For example, acute, high-level expo-
sure to carbon disulfide produces psychosis, whereas chronic 
moderate exposure causes atherosclerosis-related health ef-
fects.
2 Furthermore, few neurotoxins cause patients to present 
with pathognomic neurologic syndrome. Symptoms and signs 
of neurotoxin exposure may be mimicked by various psychiat-
ric, metabolic, inflammatory, neoplastic, and degenerative dis-
eases of the nervous system.
3
Many occupational neurologic disorders may go unrecog-
nized in Korea. In the absence of a detailed neurologic exam-
ination and comprehensive work history, physicians may over-
look the possibility of previous or current neurotoxin exposure. 
The recognition of occupational neurologic disorders is impor-
tant for clinicians for several reasons: 1) diagnosis can protect 
the worker from further harm by reducing exposure to the tox-
in, 2) diagnoses often provide some indication of prognosis, 
and 3) recognition of occupational exposure can alert the em-
ployer to the need for improved hygiene measures that will pro-
tect other workers.
South Korea has experienced rapid economic development 
since the 1960s, a phenomenon that has caused the Korean eco-
nomy to shift from labor-intensive (i.e., light) industries to ma-
chinery-intensive (i.e., heavy) industries such as automobile, pe-
trochemical, shipbuilding, nonferrous metal, machinery, and se- Kim Y et al.
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miconductor industries,
4 in which neurotoxic chemicals are wi-
dely used. Most of the carbon disulfide poisoning cases that oc-
curred in Korea in the 1980s presented with severe neurologic 
disturbances.
5 Some of the cases of poisoning that involved 
metals and organic solvents in the 1990s and 2000s manifest-
ed as mild neurologic disturbances.
6,7 Patients with occupation-
al neurologic diseases in Korea present with clinical features 
that can vary with the level of exposure.
This article schematically reviews the clinical manifestations 
of occupational neurologic disorders in Korea and discusses the 
toxicologic implications of these disorders.
Methods
We conducted an extensive search of the PubMed and Korea-
Med databases for reports of occupational neurologic disorders 
in Korea through to December 2009, and we evaluated all rel-
evant papers published in Korean and English, and the refer-
ences therein. In addition, the electronic database on occupa-
tional diseases of the Korean Worker’s Compensation and Wel-
fare Service (COMWEL) were searched thoroughly, and related 
materials on occupational neurologic disorders, such as reports 
or monthly magazines that do not appear on the PubMed and 
KoreaMed databases, were reviewed critically to identify oc-
cupational neurologic disorders.
Clinical Manifestations and  
Toxicological Implications of Major 
Neurotoxic Syndromes in Korea
Various categories of neurologic disorders, such as vascular en-
cephalopathy, parkinsonism, chronic toxic encephalopathy (CTE), 
cerebellar dysfunction, peripheral neuropathy, and neurodegen-
erative diseases, were diagnosed and compensated as occupa-
tional neurologic diseases by COMWEL. Various heavy met-
als, organic solvents, or other chemicals were found to be res-
ponsible for these occupational neurologic disorders.
Vascular encephalopathy
Carbon disulfide poisoning is a highly typical and frequently 
encountered vascular encephalopathy. Mass poisoning by car-
bon disulfide occurred at a viscose-rayon factory in Korea in 
1998. By the end of 2004, 910 workers had been compensated 
for carbon disulfide poisoning.
8 In 1964, used rayon manufac-
turing machinery that had been made by the Toray Company 
(Toyo Rayon) of Japan in 1956 was brought into the factory,
4 
which led to the use of carbon disulfide in the spinning pro-
cess at the factory.
The victims of carbon disulfide poisoning in Korea have ex-
hibited various clinical characteristics, including multiple brain 
infarctions,
5,9,10 peripheral neuropathy,
11 retinopathy including 
microaneurysm of the fundus,
12 hypertension,
13 and glomerulo-
sclerosis of the kidney.
14 These findings indicate that the basic 
mechanisms underlying the carbon disulfide poisoning cases 
in Korea involved atherosclerotic changes in blood vessels, 
consistent with a recent report by Chuang et al.
15 The clinical 
manifestations of vascular encephalopathy (e.g., hemiparesis 
and speech disturbance) in cases of chronic carbon disulfide 
poisoning were similar to those observed in patients with ath-
erosclerotic cerebrovascular disorders.
5,9,10 The main findings of 
T2-weighted brain magnetic resonance imaging (MRI) in pa-
tients with carbon disulfide poisoning in Korea included white-
matter hyperintensity and lacunar infarction.
16 Brain atrophy 
has also occasionally been reported.
15,17 Many cases present-
ing with acute cerebrovascular stroke-like symptoms, some-
times with hypertension or diabetes, were often misdiagnosed 
as having suffered cerebrovascular attacks. Thus, the possibility 
of carbon disulfide poisoning must not be overlooked when 
physicians make differential diagnoses in patients with vascu-
lar encephalopathy.
Comparing the poisoning cases in Korea with those in Ja-
pan, from which the rayon industry was transferred to Korea, 
helps to reveal the toxicological characteristics. Psychosis and 
peripheral neuropathy due to carbon disulfide poisoning were 
first reported among rayon industry workers in 1932 and 1934, 
respectively.
18 In the 1930s, during which the Japanese were 
the first to produce rayon, carbon disulfide poisoning was the 
most common occupational disease in Japan,
19 and psychosis, 
which resulted from very high exposure, was the predominant 
health problem. Since 1949, rayon manufacturers have collab-
orated with university researchers in Japan to control carbon 
disulfide concentrations in the workplace and to monitor the 
incidence of carbon disulfide poisoning.
19 Therefore, athero-
sclerosis, which is associated with moderate levels of expo-
sure, was the main type of carbon disulfide poisoning in the 
1960s in Japan.
19 Similar clinical features (e.g., atherosclerosis) 
were observed in Korean victims of carbon disulfide poison-
ing, probably due to the transfer of the rayon industries from 
Japan in the 1960s.
Many more cases have occurred in Korea than in Japan, pos-
sibly due to a lack of knowledge about the toxicity of carbon 
disulfide among occupational health professionals and a lack 
of concern regarding occupational health and safety by employ-
ers, governments, and professionals.
4
Parkinsonism
Manganism is one of the most typical forms of parkinsonism 
in Korea. Chronic excessive exposure to manganese can affect 
the globus pallidus, resulting in parkinsonian signs and symp-
toms, sometimes with psychiatric features. The mechanism un-Occupational Neurologic Disorders
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derlying this response to manganese exposure is not clear; how-
ever, it is suggested that an initial insult to the globus pallidus 
during manganese neurotoxicity can result in increased activi-
ty in the subthalamic nucleus, which is normally under tonic in-
hibition by the globus pallidus in the basal ganglia circuitry.
20 
Diagnosis of classical manganism requires a history of occu-
pational manganese exposure, typical neurologic findings such 
as bradykinesia, rigidity, and postural instability, and exclusion 
of other neurologic diseases related to the basal ganglia, such as 
Parkinson’s disease (PD), and secondary parkinsonism due to 
traumatic, vascular, or iatrogenic damage, or atypical parkin-
sonism syndromes.
21
The differential diagnoses of this disorder can be summarized 
using clinical features and neuroimaging data (Table 1).
21,22 The 
pathological lesions caused by manganism are typically de-
generative lesions of the globus pallidus, with less-frequent 
and less-severe injury to the substantia nigra (SN). However, the 
SNC is typically involved in patients with PD, whereas the 
pallidostriatal complex is spared.
23
A manganese-induced, bilateral and symmetrical increase in 
signal intensity, confined mainly to the globus pallidus, can be 
observed on T1-weighted MRI, but no alterations are typical-
ly seen on T2-weighted MRI or computed tomography (CT) 
scans. Increased signals on T1-weighted MRI were observed 
in asymptomatic manganese-exposed workers as well as in pa-
tients with experimental or occupational manganese poison-
ing.
6,24,25 However, the increased signal intensities generally 
resolve 6-12 months after the cessation of manganese expo-
sure.
25,26 Thus, a high T1 signal on MRI may reflect the target 
organ dose of recent occupational manganese exposure, but not 
necessarily manganism in the spectrum of manganese symp-
tomatology.
27
At lower exposure levels, less-severe, subtle, and preclinical 
neurobehavioral effects have been widely reported in various 
occupational and environmental settings.
28,29
Six typical cases of manganism were reported for the first 
time in Korea in 1991.
30 The patients were workers at a facto-
ry that employed approximately 20 people and had prepared 
manganese powder for welding rods by crushing ferromanga-
nese. They were exposed to manganese at a level of approxi-
mately 2.1 mg/m
3.
31 The six workers had complained of par-
kinsonian symptoms that could be differentiated from PD; 
gait disturbance (especially backward gait), postural instabili-
ty, and dystonia were prominent.
30,32 One of the patients, who 
had worked in the factory for 1 year but had resigned more 
than 10 years previously owing to tremors and gait disturbanc-
es, showed normal 
18F-6-fluorodopa uptake on positron-emis-
sion tomography (PET) without a high signal on MRI. Nor-
mal fluorodopa PET results were similar to those of previous 
findings.
22,33 The patient had negative MRI results because the 
exposure to manganese had ceased more than 10 years previ-
ously. These patients were probably exposed to moderate lev-
els of manganese, in contrast to poisoned miners who devel-
oped psychosis due to exposure to manganese at levels of up 
to several hundred milligrams per cubic meter.
34,35 These cases 
also contrast with those of welders’ parkinsonism, who were 
exposed to low levels of manganese (up to approximately 0.5 
mg/m
3).
6
Several welders were recently compensated for manganism 
in Korea.
26,36 These welders exhibited the typical clinical fea-
tures of PD, such as unilateral rigidity, tremor (predominant 
resting tremor), bradykinesia, (less-predominant) gait distur-
bance, and a persistent response to L-dopa. They were con-
currently exposed to manganese, which raised concerns about 
whether chronic exposure to low levels of manganese induces 
PD.
26,36 In fact, PD is not a single disease, but rather a hetero-
geneous group of clinically similar conditions. It is possible 
that some individuals have neurotoxin-related PD; however, 
these cases are likely to have been overlooked because most 
cases are not attributable to neurotoxin exposure. The devel-
opment of PD in the group of welders shows that Korea is con-
fronting a new class of possibly toxicant-related neurodegen-
Table 1. Comparison of the features of manganism and PD
Feature Manganism PD
Bradykinesia/Rigidity Typical Typical
Symmetry Symmetric Asymmetric
Resting tremor Less frequent, mainly action tremor More frequent
Dystonia More frequent Less frequent
Gait disturbance More frequent Less frequent
Gait Cock-walk Festinating gait
Propensity to fall backward Typical Not typical
Response to L-dopa Poor response Good response
Signal intensities in globus pallidus in T1-weighted MRI Bilaterally increased* Normal
DAT SPECT/Fluorodopa PET Normal Markedly decreased
*A negative MRI signal can occur if manganese exposure ceased at least 6 months previously.
PD: Parkinson’s disease, DAT SPECT: dopamine transporter-single-photon-emission CT. Kim Y et al.
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erative disorders that differ from typical manganese-poisoning 
cases. However, whether manganese exposure induces PD or 
affects the progress of this condition remains to be determined.
Chronic toxic encephalopathy
CTE is an established, internationally recognized condition 
that results from excessive occupational exposure to solvents 
via inhalation or skin contact. In 1985, the World Health Orga-
nization published diagnostic criteria for CTE caused by ex-
posure to solvents.
37,38 The most recent International Classifi-
cation of Diseases document (no. 10) defines the terminology 
(i.e., CTE),
39 and the Diagnostic and Statistical Manual for 
Mental Disorders, Fourth Edition
40 lists the condition as a form 
of substance-induced, persistent dementia.
The severity of CTE is graded as I-III or 1, 2A, 2B, and 3.
37,38 
Type I CTE and types 1 and 2A CTE include subjective symp-
toms relating to memory, concentration, and mood. Type II 
CTE and type 2B CTE are characterized by objective evidence 
of attention and memory deficit, decreased psychomotor func-
tion,
37 or learning deficits
38 on neurobehavioral testing. Detailed 
occupational and medical histories, as well as standardized 
neurobehavioral testing, are the cornerstones of the standard 
diagnostic process. Workers with a history of repeated episodes 
indicative of acute solvent intoxication (e.g., light-headedness, 
dizziness, headache, and nausea) over a period of many years, 
a history of insidious onset of attention, memory, and mood 
problems, and objective evidence of impairment on standard-
ized neurobehavioral tests (i.e., deficits in attention, memory, 
learning, or psychomotor function) should be considered as 
having met the diagnostic criteria for type II CTE or type 2B 
CTE. Type III CTE and type 3 CTE are often accompanied 
by neurological deficits and neuroradiologic findings. The MRI 
findings in patients with CTE are nonspecific, and hence MRI 
is useful mainly for making a differential diagnosis of CTE, 
although slight brain atrophy is associated with CTE. Thus, 
nonsolvent etiologies should be considered if there are major 
findings on the brain MRI of a patient with suspected CTE.
41
Follow-up is also important in diagnosing patients with 
CTE. Subtle changes in mental functioning due to intoxica-
tion often go unrecognized unless the clinician specifically as-
sesses these changes using sophisticated neuropsychologic tests.
Several cases of CTE have been reported in Korea (Table 
2),
42-47 with a wide spectrum of clinical signs and symptoms. 
Two-thirds of the reported cases in Korea are relatively severe, 
whereas in other countries most cases of CTE are type II or 
2B.
48 These toxicological differences may indicate that Kore-
an workers are exposed to higher levels of solvents than work-
ers in other countries. The duration of exposure is rather short 
compared with the Finnish criteria for CTE, which usually 
constitutes more than 10 years of daily exposure at work.
49 In 
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addition, Korean clinicians are not accustomed to the new con-
cept of CTE developed in European countries. Therefore, se-
vere cases were reported in earlier years and milder cases (i.e., 
similar to cases in developed countries) have been reported 
more recently.
Cerebellar dysfunction
Gait ataxia, dysarthria, intention tremor, gaze-evoked nystag-
mus, dysmetria, and adiadochokinesia result from cerebellar 
dysfunction. Cerebellar dysfunction is a clinical entity that 
can be differentiated from solvent-induced CTE or carbon-di-
sulfide-induced vascular encephalopathy. Neurotoxin-induced 
cerebellar dysfunction is sometimes accompanied by other 
neurologic findings. If a patient presents with cerebellar dys-
function, a detailed history of his or her occupation and expo-
sure to neurotoxins should be obtained.
Methyl	bromide	intoxication
Methyl bromide is a highly toxic gas that is used widely as an 
insecticidal fumigant for dry foodstuffs and can be toxic to 
both the CNS and the peripheral nervous system.
50,51 Most 
neurologic manifestations of methyl bromide intoxication oc-
cur as a result of inhalation. Chronic exposure can cause pe-
ripheral polyneuropathy, optic neuropathy, and cerebellar dys-
function, sometimes with neuropsychiatric disturbances.
50,51 
There have been five case reports of methyl bromide intoxica-
tion related to fumigation in Korea.
52-56 Two case reports de-
scribe the full spectrum of features of the intoxication (e.g., pe-
ripheral polyneuropathy, predominantly axonopathy, optic neu-
ropathy, and cerebellar dysfunction).
52,53 There are two other 
case reports that describe a patient with peripheral polyneu-
ropathy
53 and resultant erectile dysfunction.
54 A subject with 
polyneuropathy and cerebellar dysfunction showed a high 
cerebellar signal on MRI.
55 Another patient experienced cer-
ebellar dysfunction only with cerebellar atrophy, as observed 
on CT.
56 Patients who suffered from seizures and finally died 
were reported serially.
57 The common prominent features were 
cerebellar dysfunction (e.g., gait ataxia, dysarthria, intention 
tremor, gaze-evoked nystagmus, and adiadochokinesia). In 
these cases, occupational history was vital to the diagnosis of 
bromide intoxication.
Organic	tin	intoxication
Organic tins, such as the dimethyl and trimethyl compounds, 
are widely used as polyvinyl-chloride stabilizers, catalysts, and 
biocides.
58 Selective cerebellar dysfunction is most prominent 
upon recovery from coma due to acute severe organic tin in-
toxication.
58 One subject experienced selective residual and 
persistent cerebellar dysfunction such as gait ataxia, dysar-
thria, intention tremor, gaze-evoked nystagmus, dysmetria, and 
adiadochokinesia after he had cleaned a tank containing or-
ganic tins. His brain MRI exhibited cerebellar atrophy, com-
patible with the findings of 
18F-fluorodeoxyglucose PET/
CT.
59 Cerebellar ataxia is sometimes accompanied by limbic 
symptoms such as decreased memory, hallucinations, and dis-
orientation in cases of moderate organic tin intoxication.
60
It is easy to make a diagnosis of acute organic tin intoxica-
tion in patients whose work history and circumstances of ex-
posure are known and whose signs and symptoms are typical 
and consistent with those reported in the literature. 
Toxic peripheral neuropathy
Most toxic neuropathies cause symmetric effects, with a prom-
inent distal predilection for sensory and motor symptoms (i.e., 
“stocking-glove” distribution). Large fibers are commonly 
involved, and reliable early findings include the unequivocal 
loss of distal vibratory sensations and reduced or absent deep-
tendon reflexes. Most toxic peripheral neuropathies are of the 
axonal type. Unlike segmental demyelination, axonopathy us-
ually presents with normal nerve conduction velocities and 
decreased amplitude.
61 However, nerve conduction velocities 
could be decreased with secondary degeneration of the myelin 
sheath.
61 Toxic peripheral neuropathies are sometimes accom-
panied by other neurologic or systemic abnormalities, depend-
ing on the extent of exposure to the neurotoxicant. The pres-
ence of one or more of these clinical findings helps determine 
the diagnosis. Improvement over time after cessation of expo-
sure is also helpful in confirming the etiology. In the clinical 
setting, 10-40% of peripheral neuropathy cases are of unknown 
etiology.
62 
Occupational history is central to a diagnosis of toxic periph-
eral neuropathy. Table 3 lists the types of toxic peripheral neu-
ropathy cases reported in Korea.
Most cases of toxic peripheral neuropathy in Korea are sen-
sorimotor-type neuropathies of the feet and/or hands. In an 
outbreak involving n-hexane intoxication,
63 most of the 13 in-
toxicated workers complained of significant motor weakness 
as well as sensory disturbances in the feet and hands, consis-
tent with simulated workplace exposure to very high levels of 
n-hexane. Eight migratory workers with communication bar-
riers who were exposed to high levels of n-hexane also pre-
sented with significant motor weakness as well as sensory 
disturbances in the feet and hands.
64 N-hexane-induced pe-
ripheral neuropathy has been known to produce sensorimotor 
neuropathy with significant motor weakness; however, re-
cent cases of n-hexane-induced peripheral neuropathy pre-
dominantly involved sensory disturbances, probably due to low 
levels of exposure.
7,65 In addition, 2,5-hexanedione, a metab-
olite of n-hexane, caused toxic peripheral neuropathy, similar 
to recent mild cases involving n-hexane.
7,65,66 Kim Y et al.
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The clinical features of acrylamide-induced peripheral neu-
ropathy also include sensorimotor-type neuropathies in the feet 
and/or hands, which were predominantly axonopathy.
67
Neurodegenerative diseases
Amyotrophic	lateral	sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative 
disease with an annual worldwide incidence of 2-4 cases per 
100,000 individuals.
68 A few cases have been reported in Ko-
rea.
69,70 The association between ALS and exposure to solvents 
or lead is unclear, with even the best-designed incidence stud-
ies producing conflicting results.
71-73
Other	neurodegenerative	diseases
PD was dealt with under the manganism section above, and 
Alzheimer’s disease, the commonest neurodegenerative dis-
ease, has not yet been compensated or reported in Korea.
Other neurologic disorders
Inorganic	mercury	poisoning
Inorganic mercury poisoning has been known to produce gen-
eral weakness, tremors, and neuropsychiatric symptoms such 
as irritability, poor concentration, anxiety, depression, and 
emotional lability. These signs and symptoms differ from those 
caused by organic (methyl) mercury intoxication, which re-
sults predominantly in cerebellar manifestations. The symp-
toms and signs of inorganic mercury poisoning are mimicked 
by other psychiatric disorders.
74 In Korea, occupations that in-
volve exposure to inorganic mercury include fluorescent lamp 
or thermometer manufacturing, and industrial waste recy-
cling.
75-77
Multiple	sclerosis
Many factors, including both genetic and environmental, have 
been suspected of being associated with multiple sclerosis. 
Among environmental exposures, sunshine, mean annual tem-
perature, and intake of vitamin D are protective of multiple 
sclerosis.
78 Conversely, infection with certain viruses, nonbi-
ological factors such as exposure to selected heavy metals or 
organic solvents, hazardous wastes sites, outdoor air pollut-
ants, and food consumption were found to be associated with 
higher rates of multiple sclerosis in certain study populations.
78 
There are case reports linking solvents or heavy metals to mul-
tiple sclerosis in other countries,
79,80 and a few compensated 
cases due to heavy metal or solvents in Korea were confirmed 
by the electronic database of COMWEL. However, whether 
solvents or heavy metals are indeed risk factors for multiple 
sclerosis has yet to be established.
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Conclusion
CTE, vascular encephalopathy, cerebellar dysfunction, parkin-
sonism, peripheral neuropathy, and neurodegenerative diseas-
es are commonly encountered presentations of occupational 
neurotoxic syndromes in Korea. Few neurotoxins cause patients 
to present with pathognomic neurologic syndromes. The symp-
toms and signs of occupational neurologic disorders may be 
mimicked by many psychiatric, metabolic, inflammatory, neo-
plastic, and degenerative diseases of the nervous system. Detail-
ed neurologic examinations and categorization of the clinical 
manifestations of neurologic disorders will assist in the diagno-
sis of occupational neurologic diseases. Physicians must be 
aware of the typical signs and symptoms of possible exposure 
to neurotoxins, and they should also pay attention to less-typ-
ical, rather-vague symptoms and signs in workers because the 
toxicologic characteristics of occupational neurologic diseases 
in Korea have changed from typical patterns to less-typical or 
equivocal patterns. This shift is likely to be due to several years 
of low-dose exposure, perhaps combined with the effects of ag-
ing, and new types of possibly toxicant-related neurodegen-
erative diseases. Therefore, taking a patient’s comprehensive 
work history is essential to making a diagnosis of occupational 
neurologic disease, especially in subjects who may have been 
exposed to low doses. Close collaboration between neurolo-
gists and occupational physicians is needed to determine whe-
ther neurologic disorders are work-related.
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